EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of a novel inhibitor for the New Delhi metallo-β-lactamase-4: Implications for drug design and combating bacterial drug resistance

James B Thoden, Bogdan M Benin, Adam Priebe, Woo Shik Shin, Ramaiah Muthyala, Yuk Yin Sham, Hazel M Holden

Journal of Biological Chemistry · 2023

DOI: 10.1016/j.jbc.2023.105135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von James B Thoden und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Wisconsin, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: beta-Lactamases, beta-Lactamase Inhibitors, Drug Design, Anti-Bacterial Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The bacterial metallo-β-lactamases (MBLs) catalyze the inactivation of β-lactam antibiotics. Identifying novel pharmacophores remains crucial for the clinical development of additional MBL inhibitors. Previously, 1-hydroxypyridine-2(1H)-thione-6-carboxylic acid, hereafter referred to as 1,2-HPT-6-COOH, was reported as a low cytotoxic nanomolar β-lactamase inhibitor of Verona-integron-encoded metallo-β-lactamase 2, capable of rescuing β-lactam antibiotic activity. In this study, we explore its exact mechanism of inhibition and the extent of its activity through structural characterization of its binding to New Delhi metallo-β-lactamase 4 (NDM-4) and its inhibitory activity against both NDM-1 and NDM-4. Of all the structure-validated MBL inhibitors available, 1,2-HPT-6-COOH is the first discovered compound capable of forming an octahedral coordination sphere with Zn2 of the binuclear metal center. This unexpected mechanism of action provides important insight for the further optimization of 1,2-HPT-6-COOH and the identification of additional pharmacophores for MBL inhibition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-Lactamasesbeta-Lactamase InhibitorsDrug DesignAnti-Bacterial AgentsDrug Resistance, BacterialBacterial ProteinsCrystallography, X-Ray

Stichwörter der Autor:innen

antibiotic resistanceantibioticscomputational biologycrystallographyenzyme kineticsenzyme structure

Substanzen

beta-Lactamasesbeta-Lactamase Inhibitorsbeta-lactamase NDM-1Anti-Bacterial AgentsBacterial Proteins

Autor:innen und Institutionen

  • Department of Biochemistry, University of Wisconsin, Madison, Wisconsin, USA.
  • Department of Pharmaceutical Sciences, Northeast Ohio Medical University, Rootstown, Ohio, USA.
  • Department of Integrative Biology and Physiology, University of Minnesota, Minneapolis, Minnesota, USA.
  • Department of Experimental & Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA.
  • Department of Experimental & Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA; Bioinformatics and Computational Biology Program, University of Minnesota, Minneapolis, Minnesota, USA. Electroni…
  • Department of Biochemistry, University of Wisconsin, Madison, Wisconsin, USA. Electronic address: Hazel_Holden@biochem.wisc.edu.

Förderung

  • NIGMS NIH HHS
  • National Institutes of Health

Zitieren

APA

Thoden, J. B., Benin, B. M., Priebe, A., Shin, W. S., Muthyala, R., Sham, Y. Y., & Holden, H. M. (2023). Characterization of a novel inhibitor for the New Delhi metallo-β-lactamase-4: Implications for drug design and combating bacterial drug resistance. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.105135

Vancouver

Thoden JB, Benin BM, Priebe A, Shin WS, Muthyala R, Sham YY, et al. Characterization of a novel inhibitor for the New Delhi metallo-β-lactamase-4: Implications for drug design and combating bacterial drug resistance. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.105135

BibTeX
@article{Thoden2023,
  author = {Thoden, James B and Benin, Bogdan M and Priebe, Adam and Shin, Woo Shik and Muthyala, Ramaiah and Sham, Yuk Yin and Holden, Hazel M},
  title = {Characterization of a novel inhibitor for the New Delhi metallo-β-lactamase-4: Implications for drug design and combating bacterial drug resistance},
  journal = {Journal of Biological Chemistry},
  year = {2023},
  doi = {10.1016/j.jbc.2023.105135}
}
Kostenlos starten →